针对结肠的3D打印个性化平板电脑:性结肠炎管理的新方法
Yachana Mishra1, Vijay Mishra2, Alaa A A Aljabali3
1School of Bioengineering and Biosciences, Lovely Professional University, Phagwara (Punjab)-144411, India.
Current drug delivery
|September 18, 2023
概括
3D打印为炎症性肠病 (IBD) 提供个性化的药物输送系统,创建定制平板电脑来精确准结肠炎症. 这项技术有望改善性结肠炎和克罗恩病患者的治疗结果和生活质量.
科学领域:
- 制药科学 制药科学
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
背景情况:
- 炎症性肠病 (IBD),包括性结肠炎 (UC) 和克罗恩病 (CD),在全球范围内正在上升.
- 传统的药物输送方法在有效向局部结肠炎症方面面临挑战.
- 患者特定的炎症需要量身定制的治疗策略,以获得最佳的治疗.
研究的目的:
- 审查3D打印技术,以开发个性化药物输送系统 (DDS).
- 探索3D打印的潜力,为IBD患者创建定制的结肠特异性DDS.
- 突出量身定制制药品在改善患者治疗结果方面的好处.
主要方法:
- 药品行业当前3D打印工艺的概述.
- 专注于用于药物输送的基于挤出的3D打印技术.
- 对3D打印平板电脑的定制制造能力的分析.
主要成果:
- 3D打印可以创建个性化的制药产品.
- 基于挤出的3D打印是DDS开发的一个突出的技术.
- 定制制造3D打印平板电脑为结肠DDS提供了创新的解决方案.
结论:
- 3D打印技术正在变得越来越容易获得和负担得起.
- 个性化的3D打印平板可以根据个体患者的需要进行结肠药物输送.
- 未来的应用可能包括制造针对患者的UC药片,提高治疗效率和生活质量.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
168
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
168
Inflammatory Bowel Disease IV: Pharmacological Management
152
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
152
Peptic Ulcer Disease IV: Management
110
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
110
Inflammatory Bowel Disease V: Surgical Management
167
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
167
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
354
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
354
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
488
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
488


